PBM Flexibility Is Not the Same as Control: What TPAs Should Test

In pharmacy benefits, flexibility is often measured by how many options appear in a proposal. TPAs should measure it differently: how many of those options can an employer actually use without creating new operational burden?

That distinction matters. Employers increasingly want more choice in formularies, specialty strategies, pharmacy networks, clinical programs and access models. But an available option is not the same as usable control. If the contract limits the choice, the tradeoffs are unclear or the TPA must coordinate every partner and resolve every handoff, the model may be flexible in theory but difficult to operate.

1. Is there enough information to make a sound choice?

The first test is whether the employer and TPA can see the full decision. What changes financially? What changes for members? What are the clinical considerations? What data will be available? What does the client gain, give up or need to manage differently?

This is not about adding more pages to the proposal. It is about making the tradeoffs clear enough to support a responsible decision. A lower-cost formulary, for example, may create savings but also change member access, disruption risk or the level of clinical management required. The client should understand those implications before making the choice.

2. Does the contract preserve the ability to act?

The next test is whether the choice remains available after the agreement is signed. Can the client change a formulary approach or use another specialty or clinical partner? Are there restrictions, penalties or changes to guarantees? What data rights remain? How quickly can a change take effect?

PSG’s 2026 research found meaningful interest in carving out specialty pharmacy, while also identifying uncertainty about whether existing PBM contracts allowed that choice without restrictions or penalties.¹ This gap between interest and the ability to act illustrates why TPAs should examine whether flexibility remains available after the agreement is signed.

Contract limitations can be easy to overlook during the sales process. They become more important when a client wants to respond to a new cost trend, adopt a different clinical strategy or add a partner. A choice that disappears or becomes economically impractical once the contract is in place is not meaningful flexibility.

3. Can the operating model support the decision and maintain clear accountability?

Even when the employer has the information and contractual right to make a change, the work still has to get done. Benefit rules may need to change. Eligibility, accumulator or claims data may need to move differently. Partners may need to connect. Member communications and reporting may need to be updated.

The TPA should know what the PBM can configure, what requires additional implementation work and what the TPA will be expected to manage. Flexibility should not quietly turn the TPA into the pharmacy benefit integrator.

Consider a client that wants to use a different specialty approach. The contract may allow it, but the practical questions remain: Who coordinates the data feed? How are members transitioned? What happens to guarantees? Who owns the outcome, leads issue resolution and manages escalation when an issue crosses the PBM and specialty partner? Technical connectivity alone is not enough. If ownership is unclear, the option may create more burden than value.

TPAs need repeatable flexibility across the book

A single employer may want one pharmacy benefit strategy. A TPA may have many employer clients making different choices at the same time. The answer is not unlimited customization or a separate operating model for every group.

The better standard is flexibility that can be repeated across the book without creating a separate operating model for every client. Different groups should be able to make decisions that fit their priorities while claims, data, service and member support continue to work reliably.

Control has to work in practice

For TPAs, useful control means having the information to make a sound decision, the contractual authority to act, an operating model that can support the change and clear accountability when issues arise.

That is the practical test. It gives employers meaningful choices without requiring the TPA to assemble and manage the pharmacy benefit on its own. It also helps the TPA stay focused on the client relationship: solving problems, responding to changing needs and bringing forward strategies that can actually be implemented.

Put flexibility to work for your growth

What could more practical pharmacy benefit flexibility make possible for your clients—and your business? In a 30-minute TPA Growth Opportunity Review, we’ll explore how LucyRx can help you build an offering you can confidently recommend, make implementation part of your winning story and support the client relationship after the sale.